Akagera-Medicines
Do you have an idea for The New Times to cover? Submit it here!
Sunday, March 22, 2026
Subscribe Now
News
Rwanda
Business
Africa
International
Technology
Agriculture
Coronavirus
Politics
Environment
Energy
Infrastructure
Health
Crime
Finance
Law
Housing
Aviation
Tourism
Featured
Culture
Economy
Education
Security
Women
Science
Religion
Kwibuka
Opinions
Feedback from readers
Editorial
Sports
Volleyball
Cycling
Football
Basketball
Other sports
Karate
Handball
Cricket
Swimming
Tennis
AFCON 2023
Entertainment
Music
Cinema
Art
Fashion
Others
Showbiz
Videos
Jobs & Tenders
Epaper
Events
Subscribe Now
Search Results for "Akagera-Medicines" (27 articles)
What makes “a Good Company" in Rwanda?
Tuesday, March 10, 2026
Rwanda’s impossible choice
Sunday, March 08, 2026
One refugee child’s impact on hearing care in Rwanda
Friday, February 20, 2026
Rwanda’s next accomplishment: Turning Gates–OpenAI’s Horizon1000 into people‑centered AI
Tuesday, January 27, 2026
The future can be bright in the fight against TB
Wednesday, January 14, 2026
Africa “experts”: Moral certainty and local ignorance
Saturday, December 06, 2025
The next generation and Rwanda’s biotech sector
Friday, September 12, 2025
Health
Rwanda to fully digitise health records by December
Tuesday, April 22, 2025
Health
Akagera Medicines’ TB drug shows ‘promising’ results in preclinical trials
Tuesday, April 01, 2025
Health
Covid, Mpox, bird flu, MVD: Why viruses jump from animals to humans
Wednesday, December 18, 2024
Science
European Investment Bank backs Akagera’s vaccine development in Rwanda
Monday, October 14, 2024
Economy
RSSB to launch Rwf30bn equity investment facility for SMEs
Wednesday, May 29, 2024
« Prev
1
2
3
Next »